System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Giovanni B Frisoni is an expert in Neurology at University Hospital of Geneva (Switzerland). As of October 2026, ScienceLeadR ranks Giovanni B Frisoni in the top 1% of experts worldwide for Neurocognitive Disorders, Cognitive Dysfunction and Cognition Disorders. Giovanni B Frisoni has authored 1,370 publications, the most recent in 2026, and is an investigator in 13 clinical trials. SLR score: 4,618 (community average: 125). How the SLR is computed.

LeadR Profile

Giovanni B Frisoni University Hospital of Geneva Switzerland
4 618 ScienceLeadR Reputation 4618

Unlock

Register Login
Network Map

Neurology

Subspecialties: Psychiatry - Nuclear Medicine - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1992 - 2026
Source: PubMed

University Hospital of Geneva

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1370

Citations

Citations: 71 322 1st author: 123 Last author: 303 Unique author: 25

Main journals

Alzheimers Dement 406
Neurobiol Aging 74
J Alzheimers Dis 71
Lancet Neurol 37
Neurology 36

Best Journals

Lancet Neurol 16
JAMA 4
Lancet 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Amyloid, p-tau, neurofilament light, and α-synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease.
PMID 42841041 — dementia, lewy bodies, parkinson disease, alzheimer disease, pathology, biomarkers, risk factors, amyloid, synucleins, neurodegenerative diseases, cognition		Alzheimers Dement (Amst)20260
Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.
PMID 42441390 — alzheimer disease, positron-emission tomography, diagnosis, amyloid		JAMA Top journal20267
Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change.
PMID 42716047 — alzheimer disease, biomarkers, therapeutics, amyloid, nervous system		Lancet Neurol Top journal20262
SWI versus T2*GRE for ARIA-H monitoring: a pragmatic perspective on adoption in clinical practice.
PMID 42671540 — siderosis, radiography, amyloid		Neuroradiology20260
Concordance Between [ 18F]Flortaucipir PET Visual Reads and CenTauR-Based Quantification.
PMID 42562606 — positron-emission tomography, cognitive dysfunction, nuclear medicine, amyloid, roc curve		J Nucl Med20260

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 9
Phase 3 3
Phase 2 1

By status:

Completed 11
Unknown 2

By type:

Interventional 12
Observational 1

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 2
multicentric5to9 0
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 6

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS